ClinicalTrials.Veeva

Menu

Effect of Testosterone Treatment on Drug Metabolism and Transport

University of Washington logo

University of Washington

Status

Active, not recruiting

Conditions

Transgender Persons

Treatments

Drug: Acetaminophen Oral Tablet
Drug: Digoxin Oral Tablet
Drug: Midazolam oral solution

Study type

Observational

Funder types

Other

Identifiers

NCT05116293
STUDY00011644

Details and patient eligibility

About

This project will evaluate the effect of gender-affirming testosterone treatment on how other medications are processed by the body.

Full description

Gender-affirming hormone therapy may include testosterone, a hormone that the body creates and uses naturally. Testosterone is prepared as a medication that patients may take to increase hormone levels. Changes in testosterone concentrations in the body may affect how the body processes other medicines. The purpose of this study is to find out how testosterone therapy affects a single tracer dose of approved medicines in the blood (midazolam, digoxin, and acetaminophen) and to confirm testosterone treatment does not affect natural bacterial in the gut.

Enrollment

12 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Self-identified trans* adult at least 18 years of age.
  • Not taking testosterone treatment currently.
  • Planning to start testosterone treatment through care provider for gender-affirming medical care.

Exclusion criteria

  • Unwilling/unable to return for project follow-up visits.
  • Unwilling/unable to provide written informed consent.

Trial contacts and locations

1

Loading...

Central trial contact

Lauren Cirrincione, MPH, PharmD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems